Compare Cigna Corp (CI) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Robinhood Markets, Inc. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Robinhood Markets, Inc. trades at $94.7 (market cap $84.98B). The key difference: Robinhood Markets, Inc. is the larger of the two by market cap, and Cigna Corp pays a 2.24% dividend while Robinhood Markets, Inc. pays none. Which is the better fit depends on your goals.
| CI | HOOD | |
|---|---|---|
Market Cap | $73.56B | $84.98B |
Sector | Health | Technology |
52-Week High | $311.00 | $152.46 |
52-Week Low | $244.41 | $65.16 |
Enterprise Value | $98.27B | $91.53B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Robinhood (HOOD) trades at $93.29, up 2.84% today, showing strong revenue growth with 2025 revenue reaching $4.47B and net income of $1.88B. The stock faces technical headwinds with a bearish signal overall, trading near key support at $92. Recent earnings beat expectations in Q2 2026 with EPS of $0.62 versus $0.44 expected, though the company missed in Q1. Analyst sentiment remains positive with 73% buy ratings and a $123.46 consensus price target.
HOOD presents a growth opportunity with expanding product diversification and international expansion, but faces risks from competitive pressures and regulatory hurdles. Valuation metrics remain elevated with P/E of 41.28 and P/S of 17.4, requiring continued strong execution to justify current levels. The stock's near-term direction will depend on Q3 2026 earnings performance and successful execution of UK market expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
